About Novacyt

Novacyt is a rapidly growing, international diagnostics group, generating revenues from the sale of diagnostic and pathogen testing kits based on molecular and protein testing technologies and sold into human clinical, life science, food and industrial markets.

An innovative high growth diagnostic group of companies founded in 2005 and focused on the design, manufacture and supply of a growing portfolio of epidemiological and infectious disease diagnostic products.

Having secured its position as an innovator to the industry during our global response to COVID-19, Novacyt is committed to developing testing technologies that will bring simpler, faster and more accurate tests to aid in the adoption of improved clinical pathways and better patient outcomes. With an emphasis on technologies for respiratory and transplant clinical settings, Novacyt continues to drive change in how we test for disease worldwide.

We are passionate about our business and the healthcare industry sector we work with and would like to thank you for your interest in Novacyt.